{
  "id": 215415,
  "title": "Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting: a randomized controlled trial",
  "url": "https://urgent.news/2026/08/06/psilocybin-assisted-therapy-for-treatment-resistant-major-depressive",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-06T00:00:00.000Z",
  "source": {
    "name": "Nature Medicine",
    "slug": "nature-medicine",
    "url": "https://www.nature.com/articles/s41591-026-04541-0"
  },
  "original_language": "en",
  "account": "In a randomized controlled trial conducted in an NHS setting in England, psilocybin-assisted therapy showed promise in treating treatment-resistant major depressive disorder (TRD). Sixty participants were randomly assigned to either the psilocybin or placebo group, with balanced demographics. After a 6-week follow-up, the psilocybin group exhibited a significant reduction in depression severity on the Montgomery-Åsberg Depression Rating Scale (MADRS) compared to the placebo group. No serious adverse events were reported in either group, indicating the potential for psilocybin-assisted therapy to provide an effective and safe treatment option for those with TRD who have not responded to traditional antidepressant treatments.",
  "summary": "Nature Medicine, Published online: 06 August 2026; doi:10.1038/s41591-026-04541-0 In a publicly funded trial undertaken in the NHS in England, 60 adults with treatment-resistant major depression received psilocybin or placebo alongside standardized psychological support, with psilocybin showing significant improvements in depression symptoms, good tolerability and support for further research in…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}